Abstract
A high transduction efficiency, leading to a high frequency of target cleavage, is essential for efficient genome editing. However, low homology-directed repair (HDR) frequency in naïve hematopoietic stem cells, accompanied by a background of disruptive non-homologous end-joining (NHEJ), impedes the generation of therapeutic levels of edited cells. Although NHEJ is unlikely to produce adverse effects in an already non-functional gene, it will be crucial to increase the fraction of cells that undergo HDR genome editing to be successful in the clinic. Notably, this study, together with {1}, showed that inhibition of DNA ligase 4, which is required for the NHEJ pathway, not only decreases NHEJ but also increases HDR frequencies in cell lines and mouse embryos (see also {2}). This Recommendation is of an article referenced in an F1000 Faculty Review also written by Jim Vadolas, Astrid Glaser and Bradley McColl.